MLYS – mineralys therapeutics, inc. (US:NASDAQ)
Stock Stats
News
A Look at Mineralys Therapeutics (MLYS) Valuation After Findell Capital's Major New Investment [Yahoo! Finance]
Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Mineralys Therapeutics (NASDAQ:MLYS) had its price target raised by analysts at HC Wainwright from $52.00 to $56.00. They now have a "buy" rating on the stock.
Mineralys Therapeutics (NASDAQ:MLYS) had its price target raised by analysts at Wells Fargo & Company from $50.00 to $55.00. They now have an "overweight" rating on the stock.
Form 4 Mineralys Therapeutics, For: Nov 21 Filed by: Congleton Jon
Form 4 Mineralys Therapeutics, For: Nov 20 Filed by: Catalys Pacific Fund, LP
Form 144 Mineralys Therapeutics, Filed by: Catalys Pacific Fund, LP
Form 4 Mineralys Therapeutics, For: Nov 13 Filed by: Karydas Daphne
Form 4 Mineralys Therapeutics, For: Nov 11 Filed by: Levy Adam Scott
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.